Income Taxes (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Income Taxes [Abstract] |
|
| Schedule of Income Taxes Paid, Net |
The provision (benefit) for income taxes consists of the
following:
| | |
For the Fiscal Years Ended March 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Current: | |
| | |
| |
| Federal | |
$ | (42,010 | ) | |
$ | 64,300 | |
| State and local | |
| (736 | ) | |
| (63,185 | ) |
| Total current tax provision (benefit) | |
| (42,746 | ) | |
| 1,115 | |
| | |
| | | |
| | |
| Deferred: | |
| | | |
| | |
| Federal | |
| - | | |
| - | |
| State and local | |
| - | | |
| - | |
| Total deferred tax expense | |
| - | | |
| - | |
| | |
| | | |
| | |
| Total provision (benefit) | |
$ | (42,746 | ) | |
$ | 1,115 | |
|
| Schedule of Deferred Tax Assets |
The tax effects of temporary differences that give rise to
significant portions of the deferred tax assets are as follows:
| | |
As of March 31, | |
| | |
2026 | | |
2025 | |
| Deferred tax assets: | |
| | |
| |
| Net operating loss | |
$ | 1,713,110 | | |
$ | 1,416,684 | |
| Stock options | |
| 832,484 | | |
| 903,449 | |
| Operating right-of-use liability | |
| 444,981 | | |
| 519,058 | |
| Inventory | |
| 255,855 | | |
| 187,534 | |
| Capitalized research and development costs | |
| 167,957 | | |
| 241,761 | |
| Research and development tax credits | |
| 27,632 | | |
| - | |
| Deferred expenses | |
| 18,995 | | |
| - | |
| Total deferred tax assets | |
| 3,461,014 | | |
| 3,268,486 | |
| Valuation allowance | |
| (2,666,961 | ) | |
| (2,319,591 | ) |
| Deferred tax assets, net of valuation allowance | |
| 794,053 | | |
| 948,895 | |
| | |
| | | |
| | |
| Deferred tax liabilities: | |
| | | |
| | |
| Depreciation | |
| 419,146 | | |
| 492,376 | |
| Operating right-of-use asset | |
| 374,907 | | |
| 456,519 | |
| Total deferred tax liabilities | |
| 794,053 | | |
| 948,895 | |
| | |
| | | |
| | |
| Deferred tax asset (liability), net | |
$ | - | | |
$ | - | |
|
| Schedule of Change in the Company’s Valuation Allowance |
The change in the Company’s valuation allowance is
as follows:
| | |
For the Fiscal Year Ended
March 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Beginning of year | |
$ | 2,319,591 | | |
$ | 2,537,690 | |
| Increase (decrease) in valuation allowance | |
| 347,370 | | |
| (218,099 | ) |
| End of year | |
$ | 2,666,961 | | |
$ | 2,319,591 | |
|
| Schedule of Change in the Company’s Valuation Allowance |
A reconciliation of the provision for income taxes with the
amounts computed by applying the statutory Federal income tax rate to income before provision for income taxes is as follows:
| | |
For the Fiscal Year Ended March 31, 2026 | |
| | |
| | |
| |
| U.S. federal statutory rate | |
$ | (281,301 | ) | |
| 21.0 | % |
| State taxes, net of federal benefit(a) | |
| (736 | ) | |
| - | % |
| Valuation allowance | |
| 302,384 | | |
| (22.6 | )% |
| Research and development tax credit | |
| (27,632 | ) | |
| 2.1 | % |
| Nontaxable or nondeductible items | |
| | | |
| | |
| Stock-based compensation | |
| (34,230 | ) | |
| 2.6 | % |
| Home office and employee reimbursements | |
| 26,981 | | |
| (2.0 | )% |
| Other | |
| | | |
| | |
| True-up of tax provision | |
| (28,212 | ) | |
| 2.1 | % |
| Effective tax rate | |
$ | (42,746 | ) | |
| 3.2 | % |
| (a) | State
and local taxes in California and Massachusetts comprise the majority of the state taxes, net of the federal benefit. |
| | |
For the
Fiscal Year
Ended March 31,
2025 | |
| | |
| |
| U.S. federal statutory rate | |
| 21.0 | % |
| State taxes, net of federal benefit | |
| 2.2 | % |
| Stock-based compensation | |
| (0.1 | )% |
| Other | |
| 3.0 | % |
| True-up of tax provision | |
| (4.2 | )% |
| Valuation allowance | |
| (21.8 | )% |
| Effective tax rate | |
| 0.1 | % |
|
| Schedule of Income Taxes Paid, Net |
Income taxes paid, net of (refunds), are as follows:
| | |
For the
Fiscal Year
Ended March 31,
2026 | |
| | |
| |
| Federal | |
$ | (396,010 | ) |
| State and local | |
| 7,834 | |
| Total | |
$ | (388,176 | ) |
|
| Schedule of unrecognized Tax Benefits |
The following is a tabular reconciliation of the total amounts
of unrecognized tax benefits, excluding interest and penalties, for the fiscal years ended March 31, 2026 and 2025:
| | |
For the Fiscal Year Ended
March 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Unrecognized tax benefits, beginning of year | |
$ | 104,974 | | |
$ | 104,974 | |
| Decreases of tax positions taken in prior years | |
| - | | |
| - | |
| Increases based on tax positions taken in current year | |
| - | | |
| - | |
| Unrecognized tax benefits, end of year | |
$ | 104,974 | | |
$ | 104,974 | |
|